Condensed Consolidated Statements of Operations (Unaudited) (Parenthetical) - Officers Employees And Directors [Member] - USD ($) $ in Thousands	3 Months Ended	9 Months Ended
Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Research and Development Expense [Member]
Share-Based Payment Arrangement, Expense	$ 201	$ 0	$ 327	$ 0
Selling, General and Administrative Expenses [Member]
Share-Based Payment Arrangement, Expense	$ 2,743	$ 577	$ 3,527	$ 15,450

Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 718
-SubTopic 10
-Section 50
-Paragraph 2
-Subparagraph (h)(1)(i)
-URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901

Name:	us-gaap_AllocatedShareBasedCompensationExpense
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration